Cellromax Science Co., Ltd. (KOSDAQ:471820)
4,920.00
+60.00 (1.23%)
At close: Jan 23, 2026
-3.72% (1Y)
| Market Cap | 54.78B |
| Revenue | n/a |
| Net Income | n/a |
| Shares Out | 11.14M |
| EPS | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 185.00 (3.76%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 60,093 |
| Average Volume | 394,186 |
| Open | 4,860.00 |
| Previous Close | 4,860.00 |
| Day's Range | 4,835.00 - 4,980.00 |
| 52-Week Range | 4,355.00 - 7,690.00 |
| Beta | n/a |
| RSI | 35.66 |
| Earnings Date | Nov 27, 2025 |